$SMR

NuScale Power Just Solved a Major Engineering Hurdle: Is the Stock a Buy?

NuScale Power (SMR) achieved a breakthrough in fabricating boron-oxide pellets for its SMRs, a key safety component. This progress moves the company closer to commercial deployment. NuScale faces challenges, including past project cancellations and delays, but has secured supplier agreements and potential deals with ENTRA1 and TVA. The stock is down 2.79% at $8.20.

Original reporting
Published Sep 16, 2026, 1:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 2:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
NuScale Power Just Solved a Major Engineering Hurdle: Is the Stock a Buy? — source image
Decision brief

The 30-second read

$SMRBullishLow
01

Why it matters

The engineering success reduces a key technical hurdle, potentially improving project timelines and investor confidence, but without immediate financial upside.

02

Market read

Primary news for SMR; modest relevance for the broader nuclear‑energy sector.

03

What to watch

No new commercial contracts were announced, and the company still carries significant cash burn and past project failures.

Relevance 5/10Novelty 6/10Timing: recent breakthrough (Sept. 1) reported mid‑month

Background

NuScale Power (NYSE:SMR) is a small modular reactor developer that recently achieved a design approval from the NRC. The article focuses on a new engineering milestone involving boron‑oxide pellets for its passive safety system.

Company-level read

Ticker impact

$SMRBullishMedium confidence
Context

NuScale Power announced on Sept. 1 that it successfully fabricated specialized boron‑oxide pellets for its SMR emergency cooling system, a first‑time engineering breakthrough.

Expected impact

Modest upside pressure as the news may attract speculative buying in the short term.

Evidence & confidence

While the engineering step is material for the company's roadmap, it does not yet translate into revenue or contracts, limiting the magnitude of price impact.

Market effects

Demonstrates progress for the small modular reactor sector, potentially boosting interest in other SMR developers.

May positively affect nuclear‑energy related stocks in the U.S. and Europe as the technology matures.

Limited to niche clean‑energy investors; broader market impact is minimal.

Counterpoint

The breakthrough may be overstated; commercial deployment still faces regulatory, financing, and construction challenges.

Key entities

  • NuScale Power

    SMR developer listed on NYSE under ticker SMR.

  • MilleniTEK

    Collaborated with NuScale to fabricate the boron‑oxide pellets.

Related articles

$SMRHigh

Why UBS Just Turned Bearish on NuScale Power Stock

UBS downgraded NuScale Power (SMR) to 'Sell' with a $6 price target, citing competition, long build timelines, and cash burn. The bank expects $924M revenue by 2030 but negative earnings. Analysts are divided, with an average $13.22 target. NuScale shares fell 13.2%.

$SMRMed

NuScale Power Is Closing In on a Deal That Could Transform the Small Modular Reactor Industry

NuScale Power (SMR) is close to finalizing a deal with the Tennessee Valley Authority (TVA) for up to 6 gigawatts of nuclear power, which could significantly boost U.S. nuclear energy production. The company's CEO expressed optimism, but the deal is not yet final, and NuScale's stock has declined 75% over the past year. The company reported minimal revenue in Q2 but has substantial cash reserves.

$SMRHigh

NuScale Stock Falls 14% as UBS Sees a $95 Million EBITDA Gap

NuScale Power Corp. (SMR) shares dropped 13.66% after UBS downgraded it to Sell, cutting its price target to $6 from $10. Analyst Jon Windham cited extended build timelines and lack of firm customer commitments, estimating a $95 million EBITDA gap by 2028. UBS projects negative earnings throughout the forecast period, with revenue growing from $185 million in 2028 to $924 million in 2030.